Is Elevance Health Inc (NYSE: ELV) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

ELV belongs to the Healthcare sector of the NYSE while operating in the Healthcare Plans industry. The current market capitalization of Elevance Health Inc is $116.33B. A total of 1.0 million shares were traded on the day, compared to an average of 1.12M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ELV has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 28 BUYs and 26 SELLs from insiders. Insiders purchased 128,483 shares during that period but sold 62,906.

In the most recent transaction, Todt Blair Williams sold 5,492 shares of ELV for 484.02 per share on Dec 14. After the transaction, the EVP, CLO & CAO now owns 12,512 company shares. In a previous transaction on Nov 30, Penczek Ronald W sold 1,055 shares at 475.17 per share. ELV shares that CAO & Controller owns now total 1,787.

Among the insiders who sold shares, Penczek Ronald W disposed of 64 shares on Oct 24 at a per-share price of $454.35. This resulted in the CAO & Controller holding 2,842 shares of ELV after the transaction. In another insider transaction, Dixon Robert L JR sold 310 shares at $476.71 per share on Jul 21. Company shares held by the Director now total 9,638.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Elevance Health Inc pays an annual dividend of $6.24, resulting in a dividend yield of 1.26%, and it has a price to earnings (P/E) ratio of 19.67. ELV’s most recent ex-dividend date was 3/7/2024 when it declared a $1.63 quarterly dividend that was paid in cash on 3/22/2024. Previously, the company paid the dividend on 12/21/2023 with an ex-dividend date of 12/5/2023. The ELV stock dividend was $1.48 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ELV in the last 3 months, the mean price target is $570.93 with high estimates of $629.00 and low estimates of $537.00. In terms of 52-week highs and lows, ELV has a high of $501.78 and a low of $412.00.

As of this writing, ELV has an earnings estimate of $10.45 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $10.83 per share and a lower estimate of $10.08. The company reported an EPS of $8.99 in the last quarter, which was 6.50% higher than expectations of $8.44.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ELV’s latest balance sheet shows that the firm has $31.15B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $163.57, while its Total Shareholder’s Equity was $36.13B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Buy with a score of 4.79.

Most Popular

Related Posts